Image

A Prospective Cohort Study of Patients Suffering From Hand Osteoarthritis Symptoms

Recruiting
18 - 60 years of age
Both
Phase N/A

Powered by AI

Overview

The late-stage forms of degenerative osteoarthritis (OA) are very debilitating and less affordable to therapy. The main objective is to identify early onset symptoms of hand OA patients through imaging techniques (such as ultrasound and MRI). Our primary endpoint is to specify patients with high risk of radiological profression (X-ray).

Eligibility

Inclusion Criteria:

  • Early digital osteoarthritis must combine the clinical AND radiological definition.

Clinical definition:

        At least one of the following 4 criteria: Pain or stiffness or swelling or deformity of a
        digital joint (IPP and / or IPD) A breach of at least one PPI and / or IPD Age under 60 at
        the time of the first symptoms Clinical symptoms have been changing for less than 3 years
        Radiographic definition:
        The presence of the achievement of at least one PPI and / or IPD. Presence of at least two
        of the following three criteria: pinching, marginal subchondral condensation, marginal
        osteophyte Erosion on radiography is not an exclusion criteria
        - Consent form signed
        Exclusion criteria:
          -  patients suffering from rheumatoid arthritis, rheumatoid psoriasis or any other
             inflammatory rheumatism
          -  patients suffering from metabolic diseasis such as gout, hemochromatosis, Wilson's
             disease; or from congenital disease such as displasie, osteogenesis,
          -  Presence of advanced radiographic osteoarthritis based in Kellgreen Lawrence score
             (=4) in one joint among the 10 previous sites.
          -  Not able to provide a sample of blood for any reasons
          -  MRI contraindication
          -  Being in exclusion period determined by another previous study
          -  Subject non affiliated to social insurance
          -  Pregnant or lactating women
          -  Vulnerable people based in L1121-5 article of CSP
          -  Elderly subject or protected subjects disabled to give their consent
          -  Subjects private of freedom by court or administrative order

Study details

Hand Osteoarthritis

NCT03650673

University Hospital, Montpellier

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.